Novo Nordisk's CFO: "Most-favored-nation status" contributed to lower drug prices in the United States to some extent; but a more important factor is related to the larger cash business.
2026-02-04
Novo Nordisk's CFO: "Most-favored-nation status" contributed to lower drug prices in the United States to some extent; but a more important factor is related to the larger cash business.